| Quantity: | |
|---|---|
The Drug-Coated Coronary Stent System is a pioneering new class of Drug-Eluting Stent (DES) engineered for rapid vascular healing. It integrates a cobalt chromium stent platform with a biodegradable polymer and proprietary eG™ coating technology to optimize drug release kinetics and endothelialization. Unlike traditional DES, this system achieves arterial drug concentration peak at 21 days, with the biodegradable polymer fully absorbed within 60 days, eliminating long-term polymer-related inflammation risks. Preclinical data confirms reduced Evans Blue uptake, indicative of healthier endothelial cell healing and functional recovery. Clinical trials demonstrate low adverse event rates, with a 3.5% rate of cardiac death or target vessel myocardial infarction (MI) at 12 months, highlighting its safety profile. The stent’s helical connector design and lubricious distal shaft coating ensure superior deliverability, even for complex, tortuous coronary lesions.
The biodegradable polymer absorbs within 60 days, enabling unhindered reendothelialization. Arterial drug concentration peaks at 21 days, shortening the period of endothelial inhibition while maintaining anti-restenotic efficacy. This accelerated healing process reduces the risk of late-stage complications and supports long-term vascular integrity.
The proprietary electro-grafting process synthesizes a brush-like eG™ coating structure that forms a strong bond with the PLGA polymer. This ensures consistent coating performance even after tortuous-path testing and balloon expansion, as validated by scanning electron microscopy. The stable coating prevents drug loss during delivery, maximizing therapeutic effect at the target site.
The thin-strut cobalt chromium design optimizes the metal-to-artery ratio for stable scaffolding. Helical connectors balance flexibility and stability, while the lubricious distal shaft coating enhances crossability through difficult coronary anatomies. This design allows physicians to treat complex lesions with greater precision and ease.
This Drug-Coated Coronary Stent System is suitable for both small and medium-sized coronary vessels with obstructive lesions. It provides reliable scaffolding and targeted drug delivery to prevent restenosis in primary stenosis cases, supporting optimal vessel patency.
It is ideal for tortuous or calcified vessels requiring high deliverability and precise scaffolding. The system’s design adaptations address the challenges of complex anatomies, ensuring effective treatment even in hard-to-reach lesion sites.
The stent system provides long-term vessel patency support after balloon angioplasty. It targets residual narrowing to reduce restenosis risks, enhancing the overall success of coronary intervention procedures.
We lead in rapid healing DES technology, tailoring our stent to address the limitations of traditional DES by prioritizing functional endothelial recovery and reducing long-term stent-related complications. Our product boasts proven clinical safety, with clinical trial data showing low 12-month adverse event rates and long-term advantages driven by its unique healing mechanism. Additionally, the system holds CE certification (0344), complying with stringent European medical device standards for safety and performance.
eGTM coated for stronger coating integrity and more consistent results
How eG Coating is Made?
Excellent Integrity: eG coating allows the polymer to have excellent coating integrity, even after tortuous-path testing and balloon expansion (seen in scanning electron microscopy5).
Stent is submerged in a monomer solution, an electric current is applied and coating is electro-grafted to the stent.
Electric curent is cycled,causing a brush-like strcture of eG coating to be synthesized onto the surface of the stent.
The filament-like structure of the eG coating allows interdigitation of the PLGA coating, forming a strongbond.
Stent and delivery system designed for excellent deliverability
Technical Information
CorsairX CTO PTCA Balloon Catheter | |
Platform | Rapid Exchange(Rx) |
Balloon Material | PA |
Marker Material | Platinum-Iridium |
Tip Length | 3±1mm |
Distal Shaft Diameter | 0.75/0.89±0.05mm |
Proximal Shaft Diameter | 0.60±0.05mm |
Compliance | Non-compliant |
Nominal Pressure(NP) | 8 atm |
Rated Burst Pressure(RBP) | 22 atm |
Catheter Shaft Length | 140±5cm |
Maximum Guide Wire Compatibility | 0.014 inch |
Shelf Life | 24 months |
TipEntry Profile | 0.016 inch |
Ballon Crossing Profile | 0.75-1.25:0.70 mm(±0.05) |
Minimum Guiding CatheterlD | 6F/5F |
Extended Range | 0.75mm |
Order Information
Diameter | Length(mm) | ||||||
10 | 15 | 20 | 25 | 30 | 35 | 40 | |
2.25 | BMA-2.2510 | BMA-2.2515 | BMA-2.2520 | BMA-2.2525 | BMA-2.2530 | BMA-2.2535 | 一 |
2.50 | BMA-2.5010 | BMA-2.5015 | BMA-2.5020 | BMA-2.5025 | BMA-2.5030 | BMA-2.5035 | BMA-2.5040 |
2.75 | BMA-2.7510 | BMA-2.7515 | BMA-2.7520 | BMA-2.7525 | BMA-2.7530 | BMA-2.7535 | BMA-2.7540 |
3.00 | BMA-3.0010 | BMA-3.0015 | BMA-3.0020 | BMA-3.0025 | BMA-3.0030 | BMA-3.0035 | BMA-3.0040 |
3.25 | BMA-3.2510 | BMA-3.2515 | BMA-3.2520 | BMA-3.2525 | BMA-3.2530 | BMA-3.2535 | BMA-3.2540 |
3.50 | BMA-3.5010 | BMA-3.5015 | BMA-3.5020 | BMA-3.5025 | BMA-3.5030 | BMA-3.5035 | BMA-3.5040 |
4.00 | BMA-4.0010 | BMA-4.0015 | BMA-4.0020 | BMA-4.0025 | BMA-4.0030 | BMA-4.0035 | BMA-4.0040 |
4.50 | BMA-4.5010 | BMA-4.5015 | BMA-4.5020 | BMA-4.5025 | BMA-4.5030 | BMA-4.5035 | BMA-4.5040 |
5.00 | BMA-5.0010 | BMA-5.0015 | BMA-5.0020 | BMA-5.0025 | BMA-5.0030 | BMA-5.0035 | BMA-5.0040 |
A new class of DES tailored for rapid healing
Pressure | Diameter(mm) | ||||||||
2.25 | 2.50 | 2.75 | 3.00 | 3.25 | 3.50 | 4.00 | 4.50 | 5.00 | |
10 | 2.25 | 2.50 | 2.75 | 3.00 | 3.25 | 3.50 | 3.80 | 4.50 | 5.00 |
12 | 2.29 | 2.62 | 2.83 | 3.09 | 3.32 | 3.63 | 4.00 | 4.61 | 5.12 |
16 | 2.38 | 2.77 | 3.00 | 3.26 | 3.49 | 3.85 | 4.14 | 4.81 | 5.38 |
18 | 2.43 | 2.85 | 3.07 | 3.34 | 3.57 | 3.98 | 一 | 一 | 一 |
The biodegradable polymer is fully absorbed within 60 days after implantation, allowing unhindered natural vascular healing.
The stent is available in diameters from 2.25mm to 5.00mm and lengths from 10mm to 40mm, covering most clinical needs.
Yes, it is compatible with 0.014-inch guide wires, which are widely used in routine coronary interventions.
Ready to elevate your coronary intervention outcomes with our rapid-healing Drug-Coated Coronary Stent System? Contact our sales team today to inquire about pricing or request a product sample. Click Add to Basket to secure your order and experience the benefits of advanced DES technology for your patients.
